NPR's Joanne Silberner reports on the continuing controversy over a vaccine to prevent one of the leading killers of children in the so-called developing world, the rotavirus. The vaccine is currently too expensive for poor nations to afford, and the pharmaceutical companies developing the vaccine are insisting on more testing.
Copyright 2004 NPR
